Tag Archives: Regeneron Pharmaceuticals Inc.

Top Stories for Week of August 10, 2020

      No Comments on Top Stories for Week of August 10, 2020

Pfizer to help manufacture Gilead’s remdesivir for COVID-19. Pfizer Inc. (NYC) on Friday said it inked a multiyear agreement to make COVID-19 treatment remdesivir for developer Gilead Sciences Inc. (Foster… Read more »

Top Stories for Week of July 13, 2020

Fierce US surge adds over one million new coronavirus cases the past four weeks, ending months of declining national death totals. Since the first US case of the new coronavirus… Read more »

Top Stories for Week of May 4, 2020

Trump’s Warp-Speed Plan aims to produce COVID-19 vaccine this year. US President Donald Trump said on Thursday (April 30, 2020) the US plans to accelerate the development of a coronavirus… Read more »

European drug regulator comes out of hibernation in new Dutch headquarters, rivaling the FDA with rulings; well, just for one week.

It may have taken nearly 6 months and perhaps a Fourth of July holiday-shortened work week here in the US, but the European Medicines Agency (EMA) finally issued some new… Read more »

Boomer Alert: Aging immune cells increase risk for macular degeneration, blindness. Apellis, Ophthotech to the rescue?

The News: As people age, so do their immune systems. And new research at Washington University School of Medicine in St. Louis suggests that aging immune cells increase the risk… Read more »

Breakthrough gene editing reported that removes deadly embryonic mutations; biotech licks its chops as stakes are incalculable for ensuing blockbusters.

The News: Scientists have modified human embryos to remove genetic mutations that cause heart failure in otherwise healthy young people in a landmark demonstration of the controversial procedure, The Guardian… Read more »

Drugs that may shape 2017 and the trends molding new-drug discovery

Here’s a look at the drugs that may shape 2017, compliments of FirstWord Pharma. It’s a list of some of the products I agree are likely to dominate industry news… Read more »

Biotech predictions for 2017 return to positive fundamentals; 2016 meltdown still in rear-view mirror

The NASDAQ Biotech Index got hammered in 2016–-but mostly due to the market melting in January 2016. The Nasdaq Biotech Index collapsed 28% in the opening weeks of 2016 and… Read more »

Cost of New Cholesterol Drugs Unsustainable Says JAMA Study; Ensuing Debate Rages

A new study from the University of California, San Francisco, using computer models of cardiovascular disease in American adults concludes that the price of a promising new class of cholesterol-lowering… Read more »

Wall Street Ponders Brexit’s Impact on Drug, Biotech Stocks

In a historic vote Thursday, Britain has decided to leave the European Union. And, swallowing hard, financial markets around the world are not taking the news very well. Stateside, the Dow… Read more »